Neuro-Oncology Reviews

Volume 27 Number 8
20 March 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 8, 20 March

Alfonso J.
Glioblastoma's widespread integration into neuronal networks.
Nat Cancer. 2025 Mar 12. doi: 10.1038/s43018-025-00939-w. PMID: 40075239. Perspective˰ ˍ

Asfaw ZK, Young T, Brown C, Dehdia M, Huo L, Sindhu KK, Lazarev S, Samstein R, Green S, Germano IM.
Transforming Brain Tumor Care: The Global Impact of Radiosurgery in Multidisciplinary Treatment Over Two Decades.
Cancer Med. 2025 Mar 14;14(6):e70673. doi: 10.1002/cam4.70673. PMID: 40087845. Review. ˍ

Vetsika EK, Katsianou MA, Sarantis P, Palamaris K, Papavassiliou AG, Piperi C.
Pediatric gliomas immunity challenges and immunotherapy advances.
Cancer Lett. 2025 Mar 14;618:217640. doi: 10.1016/j.canlet.2025.217640. PMID: 40090572. Review˰ ˍ

Zhang X, Artz N, Steindler DA, Hingtgen S, Satterlee AB.
Exosomes: Traversing the blood-brain barrier and their therapeutic potential in brain cancer.
Biochim Biophys Acta Rev Cancer. 2025 Mar 15;1880(3):189300. doi: 10.1016/j.bbcan.2025.189300. PMID: 40097050. Review˰ ˍ

Palavani LB, Ferreira MY, Pereira MAOM, Cheidde L, de Oliveira Almeida G, Cheidde L, Júnior PPL, Pereira VGG, Bertani R, Paiva W.
Cesium 131 seeds for high-grade gliomas: a systematic review and meta-analysis of gammatile as a brachytherapy innovation.
Neurosurg Rev. 2025 Mar 17;48(1):299. doi: 10.1007/s10143-025-03429-w. PMID: 40091071. Review; Meta-analysis˰ ˍ

Di Bonaventura R, Aiudi D, Chiesa S, Pellerino A, Bruno F, Internò V, Mazzarella C, Pronello E, Colasanti R, Somma T, Ius T, Della Pepa GM, Barresi V, D'Alessandris QG, Rudà R, Silvani A.
Education paths in neuro-oncology: combining technical skills with multidisciplinary care. A survey from the AINO (Italian Association for Neuro-Oncology) Youngster Committee.
J Neurooncol. 2025 Mar 18. doi: 10.1007/s11060-025-05003-2. PMID: 40100523. Survey. ˍ

Zhou Y, He Q, Huang G, Ouyang P, Wang H, Deng J, Chen P, Liang X, Hong Z, Zhang X, Qi S, Li Y.
Malignant Cells Beyond the Tumor Core: The Non-Negligible Factor to Overcome the Refractory of Glioblastoma.
CNS Neurosci Ther. 2025 Mar 19;31(3):e70333. doi: 10.1111/cns.70333. PMID: 40104956. Review. ˍ